To elucidate transcriptomic features of SRC-3 that may be responsible for drug resistance, we employed RNA sequencing (RNA-seq) to define networks of genes in SI-2-treated myeloma cells. This evidence concerns the gene NCOA3 and plasma cell myeloma.